Latest Asarina Pharma News & Updates

See the latest news and media coverage for Asarina Pharma. We track all announcements, press releases, and industry mentions in real time, all in one place.

Company icon
Asarina Pharma

Swedish biotech developing neuroendocrinological disorder treatments

asarinapharma.com
Headquarters
Haga, Sweden
Founded year
2006
Company type
Private company
Number of employees
3–10

Last updated

Latest news about Asarina Pharma

In short: Asarina Pharma resolved to enter voluntary liquidation and sold its Sepranolone assets to Relmada Therapeutics following failed partnership efforts.

Company announcements

Asarina Pharma

Asarina Pharma applies for delisting of shares

Following a decision for voluntary liquidation on August 21, 2024, the board applies for delisting from Nasdaq First North Growth Market. Trading end date to be announced separately.

Asarina Pharma

Asarina Pharma announces extraordinary general meeting

The board proposes liquidation due to negative equity and failed partnership efforts for Sepranolone. Meeting is on 21 August 2024.

Unlock all announcements with a

Media coverage

Investing.com

Asarina Pharma Stock Price History

Explore the Asarina Pharma stock price history with detailed daily historical prices, including open, high, low, close, and volume data. Review past trends, identify key...

Life Science Sweden

Receives funding for study on severe PMS

The biotech company Asarina Pharma (formerly Umecrine Mood) announces today Wednesday that the company has raised new capital to conduct a phase IIb study with its drug candidate...

Unlock all articles with a

Never miss news about Asarina Pharma

Track Asarina Pharma and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Trending companies

Discover what's making headlines across other trending companies.